A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia
- PMID: 38963076
- PMCID: PMC11446129
- DOI: 10.5664/jcsm.11250
A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia
Abstract
Study objectives: Idiopathic hypersomnia (IH) is characterized by excessive sleepiness during the day, prolonged sleep at night, and difficulty waking up. The true prevalence of IH is uncertain. The International Classification of Sleep Disorders provides criteria for diagnosing IH; however, the definition has evolved. Managing IH involves using pharmacologic and nonpharmacologic approaches, although the most effective strategies are still unclear. The objective of this scoping review was to identify the extent, range, and nature of the available evidence, identify research gaps, and discuss the implications for clinical practice and policy.
Methods: To conduct this review, a comprehensive search was conducted across scientific databases, without any restrictions on the date or study type. Eligible studies examined the effectiveness of pharmacologic and nonpharmacologic treatments for IH and reported the outcomes of these interventions. Data from the studies were screened, analyzed, and synthesized to provide an overview of the available literature landscape.
Results: Fifty-one studies were included in this review, which used various methods and interventions. Pharmacological treatments, particularly modafinil, have been frequently studied and have yielded positive results. There is also emerging evidence for alternative medications such as low-sodium oxybate and pitolisant. Nonpharmacological approaches, such as cognitive behavioral therapy for hypersomnia and transcranial direct current stimulation have also shown promise in managing IH.
Conclusions: This review highlights the complexity of managing IH symptoms and emphasizes the need for personalized multidisciplinary approaches. Pharmacological interventions are important in managing IH and can be complemented by nonmedication strategies. Larger-scale studies are necessary to advance our understanding of IH and to improve treatment outcomes.
Citation: Saini V, Saini S. A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia. J Clin Sleep Med. 2024;20(10):1685-1704.
Keywords: ICSD criteria; central disorders of hypersomnolence; cognitive behavioral therapy; excessive daytime sleepiness; idiopathic hypersomnia; low-sodium oxybate; modafinil; narcolepsy; pitolisant; sleep disorders; transcranial direct current stimulation; wakefulness.
© 2024 American Academy of Sleep Medicine.
Conflict of interest statement
All authors have seen and approved the manuscript. The institution where work was performed: Sound Asleep Sleep Lab. The authors report no conflicts of interest.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2. Cochrane Database Syst Rev. 2023. PMID: 37811711 Free PMC article.
References
-
- Nevsimalova S , Susta M , Prihodova I , Horvat EM , Milata M , Sonka K . Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med. 2021. ; 80 : 86 – 91 . - PubMed
-
- Nishino S . Narcolepsy and idiopathic hypersomnia . In: Sleep Disorders Medicine. New York, NY: : Springer New York; ; 2017. : 697 – 711 .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources